Tower Research Capital LLC (TRC) - PROTAGENIC THERAPEUTICS INC ownership

PROTAGENIC THERAPEUTICS INC's ticker is PTIX and the CUSIP is 74365N103. A total of 18 filers reported holding PROTAGENIC THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PROTAGENIC THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$2
-100.0%
6,206
-4.9%
0.00%
Q3 2022$4,0000.0%6,527
+7.7%
0.00%
Q2 2022$4,0000.0%6,063
+39.5%
0.00%
Q1 2022$4,000
-63.6%
4,345
-45.1%
0.00%
Q4 2021$11,000
+266.7%
7,917
+356.8%
0.00%
Q3 2021$3,0001,7330.00%
Other shareholders
PROTAGENIC THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
FNY Investment Advisers, LLC 75,000$61,0000.06%
ORACLE INVESTMENT MANAGEMENT INC 20,000$16,0000.00%
Virtu Financial LLC 13,045$11,0000.00%
Renaissance Technologies 102,200$83,0000.00%
ROYAL BANK OF CANADA 1$00.00%
VANGUARD GROUP INC 252,825$206,0000.00%
UBS Group AG 2,393$2,0000.00%
OSAIC HOLDINGS, INC. 5,055$4,0000.00%
BANK OF AMERICA CORP /DE/ 4$00.00%
WELLS FARGO & COMPANY/MN 85$00.00%
View complete list of PROTAGENIC THERAPEUTICS INC shareholders